Position statement on radiopharmaceutical production for clinical trials

The EU regulation 536/2014 aims to facilitate the experimental use of diagnostic radiopharmaceuticals in particular for GMP requirements and needs to be applied in EU countries. As definitely clarified by this survey, the application is still far from being completed due to national restrictions tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Bormans, G., Buck, A., Chiti, A., Cooper, M., Croasdale, J., Desruet, M., Kumar, V., Liu, Y., Penuelas, I., Rossetti, C., Schiavo, R., Schwarz, S. W., Windhorst, A. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Position Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824698/
https://www.ncbi.nlm.nih.gov/pubmed/29503853
http://dx.doi.org/10.1186/s41181-017-0031-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824698/
https://www.ncbi.nlm.nih.gov/pubmed/29503853
http://dx.doi.org/10.1186/s41181-017-0031-y

Ejemplares similares